Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

NCT04566614 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT04566614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04566614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
June 18, 2020
Completion date
January 31, 2025
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms, gastro intestinal stromal tumour, neoplasm of lung, neoplasm, bladder, neoplasm, colorectal, neoplasms pancreatic